Cargando…
DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells
BACKGROUND: High-grade gliomas are primary brain cancers with unacceptably low and persistent survival rates of 10–16 months for WHO grade 4 gliomas over the last 40 years, despite surgical resection and DNA-damaging chemo-radiotherapy. More recently, tumour-treating fields therapy (TTFields) has de...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667536/ https://www.ncbi.nlm.nih.gov/pubmed/37777579 http://dx.doi.org/10.1038/s41416-023-02454-0 |